| 1 |
35307915 | Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer. | 2022 Jun |
1 |
| 2 |
32815556 | Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer. | 2021 Mar |
6 |
| 3 |
32918990 | Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux. | 2021 Jan 10 |
1 |
| 4 |
33390536 | Functional Alterations of Multidrug Resistance-Associated Proteins 2 and 5, and Breast Cancer Resistance Protein upon Snail-Induced Epithelial-Mesenchymal Transition in HCC827 Cells. | 2021 |
1 |
| 5 |
34399762 | Nitric oxide-releasing micelles with intelligent targeting for enhanced anti-tumor effect of cisplatin in hypoxia. | 2021 Aug 16 |
2 |
| 6 |
31926942 | ISG15 suppresses translation of ABCC2 via ISGylation of hnRNPA2B1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells. | 2020 Apr |
1 |
| 7 |
32037720 | Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells. | 2020 Apr |
1 |
| 8 |
32377314 | Renoprotective Effects of a New Free Radical Scavenger, XH-003, against Cisplatin-Induced Nephrotoxicity. | 2020 |
2 |
| 9 |
31646427 | Encapsulation of crocetin into poly (lactic-co-glycolic acid) nanoparticles overcomes drug resistance in human ovarian cisplatin-resistant carcinoma cell line (A2780-RCIS). | 2019 Dec |
1 |
| 10 |
29848100 | Ovarian cancer cells cisplatin sensitization agents selected by mass cytometry target ABCC2 inhibition. | 2018 Jun 1 |
2 |
| 11 |
27435393 | Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder. | 2017 Jan 15 |
1 |
| 12 |
28386339 | MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2. | 2017 |
2 |
| 13 |
28422153 | Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma. | 2017 Apr 19 |
1 |
| 14 |
28423482 | Clerosterol from vinegar-baked radix bupleuri modifies drug transport. | 2017 Mar 28 |
1 |
| 15 |
29069816 | Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells. | 2017 Sep 22 |
1 |
| 16 |
29299132 | Saikosaponins A, C and D enhance liver-targeting effects of anticancer drugs by modulating drug transporters. | 2017 Dec 15 |
1 |
| 17 |
26721606 | Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin. | 2016 Jan 22 |
1 |
| 18 |
27330316 | Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression. | 2016 |
4 |
| 19 |
27602148 | Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2. | 2016 Sep |
8 |
| 20 |
25554586 | Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis. | 2015 Mar |
1 |
| 21 |
26239260 | Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells. | 2015 Oct |
1 |
| 22 |
26295158 | Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5'-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic Drugs. | 2015 |
1 |
| 23 |
24641901 | Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice. | 2014 May |
4 |
| 24 |
24913304 | A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels. | 2014 Oct |
1 |
| 25 |
23381786 | Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells. | 2013 Apr |
3 |
| 26 |
23420099 | Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin. | 2013 Feb |
2 |
| 27 |
23876835 | Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway. | 2013 Oct |
1 |
| 28 |
24041618 | Combination of arsenic trioxide and chemotherapy in small cell lung cancer. | 2013 Nov |
1 |
| 29 |
24400442 | Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL. | 2013 Dec |
1 |
| 30 |
22534871 | Associations between ABCC2 polymorphisms and cisplatin disposition and efficacy. | 2012 Jun |
4 |
| 31 |
22800197 | Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins. | 2012 Sep 4 |
4 |
| 32 |
21206495 | Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma. | 2011 Feb 15 |
4 |
| 33 |
21687948 | 'Genetic profiling' and ovarian cancer therapy (review). | 2011 Sep-Oct |
1 |
| 34 |
20204280 | Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma. | 2010 Apr |
6 |
| 35 |
20331629 | Quantitative analysis of cisplatin sensitivity of human esophageal squamous cancer cell lines using in-air micro-PIXE. | 2010 Jun |
1 |
| 36 |
20628484 | Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line. | 2010 |
12 |
| 37 |
20013091 | Radiation- and chemoinduced multidrug resistance in colon carcinoma cells. | 2009 Dec |
1 |
| 38 |
18834541 | Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin. | 2008 Oct 4 |
5 |
| 39 |
19020751 | Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer. | 2008 Dec |
12 |
| 40 |
17190787 | Characteristic expression of Lewis-antigenic glycolipids in human ovarian carcinoma-derived cells with anticancer drug-resistance. | 2007 Mar |
1 |
| 41 |
17276588 | Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell. | 2007 Jul 18 |
1 |
| 42 |
17704753 | Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs. | 2007 Nov |
1 |
| 43 |
16213010 | MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma. | 2006 Feb |
8 |
| 44 |
16341694 | Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract. | 2006 Jun |
3 |
| 45 |
16831027 | Immunoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary thyroid carcinomas. | 2006 Jul |
1 |
| 46 |
16876126 | RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells. | 2006 Sep 15 |
6 |
| 47 |
16995873 | Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. | 2006 Dec |
1 |
| 48 |
17145840 | ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome. | 2006 Dec 1 |
5 |
| 49 |
15688364 | Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells. | 2005 Jun 20 |
2 |
| 50 |
16080518 | Involvement of ABC transporters in chemosensitivity of human renal cell carcinoma, and regulation of MRP2 expression by conjugated bilirubin. | 2005 Jul-Aug |
1 |